posted on 2022-02-08, 10:37authored byRV Chudasama, K Khunti, WC Ekezie, M Pareek, F Zaccardi, CL Gillies, S Seidu, MJ Davies, YV Chudasama
Background and aims
Vaccine hesitancy is an ongoing major challenge. We aimed to assess the uptake and hesitancy of the COVID-19 vaccination.
Methods
A short online survey was posted between April 12 to July 31, 2021 targeted at health and social care workers (HCWs) across the globe.
Results
275 from 37 countries responded. Most were hospital or primary care physicians or nurses, 59% women, aged 18–60 years, and 21% had chronic conditions with most prevalent being diabetes, hypertension, and asthma. We found that most HCWs (93%) had taken or willing to receive the COVID-19 vaccine. While 7% were vaccine hesitant (mainly women aged 30–39 years), respondents main concerns was the safety or potential side effects. Vaccine willing respondents raised concerns of unequal access to the COVID-19 vaccination in some countries, and highlighted that the only solution to overcoming COVID-19 infections was the vaccine booster doses given annually and free mass vaccination.
Conclusions
This study found that the majority of the frontline HCWs are willing to receive the COVID-19 vaccine. Further promotion of the COVID-19 vaccine would reassure and persuade HCWs to become vaccinated.
Funding
We acknowledge the support from the National Institute for Health Research (NIHR) Applied Research Collaboration East Midlands (ARC EM), and the NIHR Leicester Biomedical Research Centre.
History
Citation
Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Volume 16, Issue 1, January 2022, 102361
Author affiliation
Department of Respiratory Sciences, University of Leicester
Version
AM (Accepted Manuscript)
Published in
Diabetes and Metabolic Syndrome: Clinical Research and Reviews